Literature DB >> 3868411

Phaeochromocytoma in Queensland--1970-83.

L Hartley, D Perry-Keene.   

Abstract

A statewide survey was conducted in Queensland to record all cases of phaeochromocytoma between the years of 1970 and 1983 inclusive. There were 46 cases giving an incidence of 1.55/million population per year. Twenty-nine patients (63%) were successfully treated while 10 patients (22%) died of the tumour effects. Seven cases (15%) were found incidentally at autopsy, though at least one showed diagnostic clinical features before death. Five patients (11%) had extra adrenal phaeochromocytoma, five patients (11%) had multiple tumours, four patients (9%) had multiple endocrine neoplasia and three patients (7%) had clinically malignant tumours. Of 13 patients suffering a major adrenergic crisis only six survived. Five patients with unsuspected phaeochromocytoma suffered crisis under anaesthesia and only one survived. Only one of the patients dying of benign phaeochromocytoma had adequate ante mortem adrenergic blockade. Of all patients in the series 35% were not diagnosed in life.

Entities:  

Mesh:

Year:  1985        PMID: 3868411

Source DB:  PubMed          Journal:  Aust N Z J Surg        ISSN: 0004-8682


  14 in total

1.  Continued Tumor Reduction of Metastatic Pheochromocytoma/Paraganglioma Harboring Succinate Dehydrogenase Subunit B Mutations with Cyclical Chemotherapy.

Authors:  Irfan Jawed; Margarita Velarde; Roland Därr; Katherine I Wolf; Karen Adams; Aradhana M Venkatesan; Sanjeeve Balasubramaniam; Marianne S Poruchynsky; James C Reynolds; Karel Pacak; Tito Fojo
Journal:  Cell Mol Neurobiol       Date:  2018-04-05       Impact factor: 5.046

2.  Spectrum of pheochromocytoma in the 131I-MIBG era.

Authors:  P S Cheung; N W Thompson; C F Dmuchowski; J C Sisson
Journal:  World J Surg       Date:  1988-08       Impact factor: 3.352

3.  Paraganglioma: not just an extra-adrenal pheochromocytoma.

Authors:  Amanda M Laird; Paul G Gauger; Gerard M Doherty; Barbra S Miller
Journal:  Langenbecks Arch Surg       Date:  2011-11-17       Impact factor: 3.445

4.  Frequency of pheochromocytoma in adrenal incidentalomas and utility of the glucagon test for the diagnosis.

Authors:  G P Bernini; M S Vivaldi; G F Argenio; A Moretti; M Sgrò; A Salvetti
Journal:  J Endocrinol Invest       Date:  1997-02       Impact factor: 4.256

5.  Changing pattern of pheochromocytoma and paraganglioma in a stable UK population.

Authors:  I T Cvasciuc; S Gull; R Oprean; K H Lim; F Eatock
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Jan-Mar       Impact factor: 0.877

Review 6.  Hereditary paraganglioma targets diverse paraganglia.

Authors:  B E Baysal
Journal:  J Med Genet       Date:  2002-09       Impact factor: 6.318

7.  Phaeochromocytoma: intraoperative changes in blood pressure and plasma catecholamines.

Authors:  A L Tonkin; D B Frewin; W J Russell; J R Jonsson
Journal:  Clin Auton Res       Date:  1994-08       Impact factor: 4.435

Review 8.  Molecular and therapeutic advances in the diagnosis and management of malignant pheochromocytomas and paragangliomas.

Authors:  Aoife J Lowery; Siun Walsh; Enda W McDermott; Ruth S Prichard
Journal:  Oncologist       Date:  2013-04-10

9.  A rare and life-threatening cause of pseudo-obstruction in two surgical patients.

Authors:  A C de Lloyd; S Munigoti; J S Davies; D Scott-Coombes
Journal:  BMJ Case Rep       Date:  2010-11-23

10.  Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: recommendation from a 22-year follow-up of 18 patients.

Authors:  Hui Huang; Jame Abraham; Elizabeth Hung; Steven Averbuch; Maria Merino; Seth M Steinberg; Karel Pacak; Tito Fojo
Journal:  Cancer       Date:  2008-10-15       Impact factor: 6.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.